Literature DB >> 27926856

Insulin-Dependent Activation of MCH Neurons Impairs Locomotor Activity and Insulin Sensitivity in Obesity.

A Christine Hausen1, Johan Ruud1, Hong Jiang1, Simon Hess2, Hristo Varbanov2, Peter Kloppenburg2, Jens C Brüning3.   

Abstract

Melanin-concentrating-hormone (MCH)-expressing neurons (MCH neurons) in the lateral hypothalamus (LH) are critical regulators of energy and glucose homeostasis. Here, we demonstrate that insulin increases the excitability of these neurons in control mice. In vivo, insulin promotes phosphatidylinositol 3-kinase (PI3K) signaling in MCH neurons, and cell-type-specific deletion of the insulin receptor (IR) abrogates this response. While lean mice lacking the IR in MCH neurons (IRΔMCH) exhibit no detectable metabolic phenotype under normal diet feeding, they present with improved locomotor activity and insulin sensitivity under high-fat-diet-fed, obese conditions. Similarly, obesity promotes PI3 kinase signaling in these neurons, and this response is abrogated in IRΔMCH mice. In turn, acute chemogenetic activation of MCH neurons impairs locomotor activity but not insulin sensitivity. Collectively, our experiments reveal an insulin-dependent activation of MCH neurons in obesity, which contributes via distinct mechanisms to the manifestation of impaired locomotor activity and insulin resistance.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MCH; PI3K; energy homeostasis; glucose homeostasis; insulin receptor; insulin signaling; lateral hypothalamus; locomotor activity; selective insulin resistance

Mesh:

Substances:

Year:  2016        PMID: 27926856     DOI: 10.1016/j.celrep.2016.11.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

Review 1.  Chemogenetic Tools for Causal Cellular and Neuronal Biology.

Authors:  Deniz Atasoy; Scott M Sternson
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 2.  Remote control of glucose-sensing neurons to analyze glucose metabolism.

Authors:  Alexandra Alvarsson; Sarah A Stanley
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-05-29       Impact factor: 4.310

3.  PI3K and AKT at the Interface of Signaling and Metabolism.

Authors:  Giovanni Solinas; Barbara Becattini
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

4.  Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function.

Authors:  Jin Kwon Jeong; Julie A Horwath; Hayk Simonyan; Katherine A Blackmore; Scott D Butler; Colin N Young
Journal:  Physiol Genomics       Date:  2019-06-07       Impact factor: 4.297

Review 5.  Insulin action in the brain: cell types, circuits, and diseases.

Authors:  Wenqiang Chen; Weikang Cai; Benjamin Hoover; C Ronald Kahn
Journal:  Trends Neurosci       Date:  2022-03-28       Impact factor: 16.978

Review 6.  Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.

Authors:  Akihiko Ozawa; Hiroyuki Arakawa
Journal:  Behav Brain Res       Date:  2021-03-16       Impact factor: 3.332

Review 7.  Melanin-concentrating hormone and food intake control: Sites of action, peptide interactions, and appetition.

Authors:  Magen N Lord; Keshav Subramanian; Scott E Kanoski; Emily E Noble
Journal:  Peptides       Date:  2020-12-25       Impact factor: 3.750

Review 8.  Central actions of insulin during pregnancy and lactation.

Authors:  Sharon R Ladyman; Virginia L Brooks
Journal:  J Neuroendocrinol       Date:  2021-03-12       Impact factor: 3.870

9.  Homeostatic Regulation of Glucose Metabolism by the Central Nervous System.

Authors:  Jong Han Choi; Min-Seon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28

Review 10.  Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis.

Authors:  Omar Al-Massadi; Carlos Dieguez; Marc Schneeberger; Miguel López; Markus Schwaninger; Vincent Prevot; Ruben Nogueiras
Journal:  Nat Rev Endocrinol       Date:  2021-10-04       Impact factor: 47.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.